Medxy AI

Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes

By MedXY 04/25/2026

A study reveals that combining GLP-1 receptor agonists with SGLT-2 inhibitors significantly lowers the risk of major adverse liver and cardiovascular outcomes in patients with MASLD and type 2 diabetes compared to monotherapy.

Gastroenterology Infectious Diseases news

CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity

By MedXY 04/25/2026

A study reveals CD16+ γδ T cells as key mediators of antibody-dependent cellular cytotoxicity in HBV infection, correlating with reduced viral replication and offering new therapeutic targets.

$Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease$

Gastroenterology Hematology-Oncology news

Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease

By MedXY 04/25/2026

This study uncovers clonal lymphocyte expansions and JAK-STAT pathway mutations as key drivers of refractory celiac disease, suggesting a shared pathogenic continuum between RCD1 and RCD2 while cautioning against JAK inhibitor monotherapy due to resistance risks.

Neurology news

EVT Shows Superior Outcomes in Anterior Cerebral Artery Occlusion Stroke: Insights from the ORIENTAL-MeVO Registry

By MedXY 04/25/2026

Endovascular thrombectomy (EVT) significantly improves 90-day functional outcomes in acute anterior cerebral artery occlusion stroke compared to standard medical management, without increasing hemorrhage or mortality risks, per the ORIENTAL-MeVO Registry.

Neurology news

Optimal Sleep Duration Mitigates Cognitive Decline and Dementia Risk in Focal Epilepsy: Insights from the UK Biobank Study

By MedXY 04/25/2026

A UK Biobank study reveals that optimal sleep (6-8 hours) improves executive function and reduces dementia risk in focal epilepsy patients, with effects surpassing those in stroke patients. Nonoptimal sleep exacerbates cognitive deficits up to 8 years pre-diagnosis.

Diabetes & Endocrinology news

uGMI: A More Accurate Alternative to HbA1c for Diabetes Management

By MedXY 04/24/2026

The updated glucose management indicator (uGMI) significantly improves alignment with HbA1c, reducing discordance, particularly in high and low glucose ranges, offering clinicians a more reliable tool for diabetes monitoring.

Endocrinology news Oncology

Advancing Personalized Treatment in Papillary Thyroid Cancer: A Machine-Learning Model for Predicting Occult Lymph Node Metastasis

By MedXY 04/24/2026

A novel machine-learning model incorporating clinical, ultrasonographic, and molecular features predicts occult central lymph node metastasis in papillary thyroid cancer, with RET fusion positivity identified as a key risk factor.

Diabetes & Endocrinology news Public Health

Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome

By MedXY 04/24/2026

A study of 1,454 older adults with metabolic syndrome reveals that long-term exposure to air pollutants like black carbon, PM2.5, and NO2 is associated with increased fat mass and decreased lean mass, persisting over three years, particularly in those under 65.

Cardiology news

Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed

By MedXY 04/24/2026

A study finds bradykinin modestly contributes to blood pressure reduction with sacubitril/valsartan in chronic heart failure, highlighting ANP's role in initial effects and bradykinin's influence during chronic therapy.

Cardiology Emergency Medicine news

Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity

By MedXY 04/24/2026

A novel sixth-gen hs-cTnT assay with a 13 ng/L threshold safely identified twice as many low-risk MI patients at ED presentation vs fifth-gen assays, achieving >99.5% NPV in multinational validation.

Cardiology Hematology-Oncology news

Blocking P2Y14R Emerges to Combat Venous Thromboembolism via Neutrophil-Plaque Interaction

By MedXY 04/24/2026

New research identifies P2Y14R as a key regulator of neutrophil-platelet aggregates and NET formation in venous thrombosis, with proglumide showing promise as a therapeutic antagonist.

Cardiology news

Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients

By MedXY 04/24/2026

A randomized trial shows left bundle branch pacing significantly reduces the risk of pacing-induced cardiomyopathy and improves cardiac function compared to right ventricular pacing in high-risk patients.

Cardiology news Pediatrics

Pediatric Hypertrophic Cardiomyopathy: The High-Risk Profile of Massive Left Ventricular Hypertrophy

By MedXY 04/24/2026

A multiregistry analysis reveals that massive LVH in pediatric HCM is linked to early diagnosis, sarcomeric mutations, and heightened risks of arrhythmias, heart failure, and mortality. Nearly 25% of patients show significant LVH regression over time.

Hematology-Oncology news

2/20/20 Model Outperforms AQUILA Criteria in Identifying High-Risk Smoldering Multiple Myeloma

By MedXY 04/24/2026

The 2/20/20 risk stratification model identifies a smaller, truly high-risk SMM group with higher progression rates than the AQUILA trial criteria, suggesting better targeting for early intervention.

Critical Care Infectious Diseases news

Cultural Diversity in ICU: A Protective Factor Against Sepsis Mortality

By MedXY 04/24/2026

A multicenter study reveals that culturally and linguistically diverse patients with sepsis had lower in-hospital mortality and shorter ICU stays compared to non-CaLD patients, challenging prior assumptions about healthcare disparities.

Cardiology Emergency Medicine news

LEGEND Trial: A Game-Changer in Rapid Rule-Out of Acute Myocardial Infarction in the ED

By MedXY 04/24/2026

The LEGEND trial demonstrates that a high-sensitivity troponin-based rule-out strategy significantly reduces hospital length of stay and cardiac testing while safely excluding acute myocardial infarction in emergency department patients.

Internal Medicine news Oncology

Video Declarations: Bridging the Gap in Advanced Cancer Care Conversations

By MedXY 04/24/2026

A study explores how video declarations from advanced cancer patients can enhance goals of care discussions by focusing on decision-making factors rather than specific medical interventions, offering a patient-centered tool for advance care planning.

Family Medicine & Nutrition Neurology news

Dementia Screening for Family Members: No Clear Benefit or Harm Found in Landmark Trial

By MedXY 04/24/2026

A randomized clinical trial found that dementia screening for family members of older adults did not improve quality of life or caregiver preparedness, nor did it increase depression or anxiety.

Neurology news Respiratory

Proximal Hypoglossal Nerve Stimulation Shows Promise for Moderate-to-Severe OSA in Landmark OSPREY Trial

By MedXY 04/24/2026

A recent randomized controlled trial demonstrates that proximal hypoglossal nerve stimulation significantly improves obstructive sleep apnea symptoms in patients intolerant to positive airway pressure therapy.

Infectious Diseases Neurology news

Combination Antiviral Therapy Improves Survival in HHV-6B Encephalitis Post-Cord Blood Transplant

By MedXY 04/24/2026

A real-world study reveals FCN/GCV combination therapy enhances 1-year survival in HHV-6B encephalitis post-CBT, particularly after neutrophil engraftment, compared to monotherapy. Findings underscore the need for tailored antiviral strategies based on hematologic recovery.